Buller HR - Search Results

1

Recurrent thromboembolism after treatment with vitamin K antagonists.

van Dongen CJ, Vink R, Hutten BA, Buller HR, Prins MH. van Dongen CJ, et al. Among authors: buller hr. Arch Intern Med. 2003 Dec 8-22;163(22):2793. doi: 10.1001/archinte.163.22.2793-a. Arch Intern Med. 2003. PMID: 14662641 No abstract available.

2

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.

van Dongen CJ, Vink R, Hutten BA, Büller HR, Prins MH. van Dongen CJ, et al. Among authors: buller hr. Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064

3

The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis.

ten Wolde M, Kraaijenhagen RA, Prins MH, Büller HR. ten Wolde M, et al. Among authors: buller hr. Arch Intern Med. 2002 Sep 9;162(16):1880-4. doi: 10.1001/archinte.162.16.1880. Arch Intern Med. 2002. PMID: 12196087

4

Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis.

Locadia M, Sprangers MA, de Haes HC, Büller HR, Prins MH. Locadia M, et al. Among authors: buller hr. Thromb Haemost. 2003 Jul;90(1):101-7. Thromb Haemost. 2003. PMID: 12876632 Clinical Trial.

5

Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

van Dongen CJ, Prins MH, Büller HR. van Dongen CJ, et al. Among authors: buller hr. N Engl J Med. 2003 Jul 24;349(4):398-400; author reply 398-400. doi: 10.1056/NEJM200307243490417. N Engl J Med. 2003. PMID: 12878749 No abstract available.

6

Secondary prophylaxis with warfarin for venous thromboembolism.

Büller HR, Prins MH. Büller HR, et al. N Engl J Med. 2003 Aug 14;349(7):702-4. doi: 10.1056/NEJMe038112. N Engl J Med. 2003. PMID: 12917308 Free article. No abstract available.

7

The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis.

Vink R, Kraaijenhagen RA, Hutten BA, van den Brink RB, de Mol BA, Büller HR, Levi M. Vink R, et al. Among authors: buller hr. J Am Coll Cardiol. 2003 Dec 17;42(12):2042-8. doi: 10.1016/j.jacc.2003.07.029. J Am Coll Cardiol. 2003. PMID: 14680724 Free article.

8

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR. Bank I, et al. Among authors: buller hr. Arch Intern Med. 2004 Sep 27;164(17):1932-7. doi: 10.1001/archinte.164.17.1932. Arch Intern Med. 2004. PMID: 15451770

9

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR. Strebel N, et al. Among authors: buller hr. Arch Intern Med. 2002 Jul 8;162(13):1451-6. doi: 10.1001/archinte.162.13.1451. Arch Intern Med. 2002. PMID: 12090880 Review.

10

Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review.

Kruip MJ, Leclercq MG, van der Heul C, Prins MH, Büller HR. Kruip MJ, et al. Among authors: buller hr. Ann Intern Med. 2003 Jun 17;138(12):941-51. doi: 10.7326/0003-4819-138-12-200306170-00005. Ann Intern Med. 2003. PMID: 12809450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters